Cycladex

company

About

Cycladex has now developed a cheaper process which will reduce operating costs.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$179.99K
Industries
Health Care
Number Of Employee
11 - 50
Operating Status
Active

Cycladex has now developed a cheaper process which will reduce operating costs by approximately 30-50% and capital costs by 35-50%. It also has the advantage of using environmentally friendly chemicals eliminating the need to use the expensive Sodium Cyanide.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$892.21K
Cycladex has raised a total of $892.21K in funding over 2 rounds. Their latest funding was raised on Mar 20, 2016 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 20, 2016 Grant $712.21K 1 National Science Foundation Detail
Dec 8, 2014 Grant $179.99K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Cycladex is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant